← Mechanisms of action
CD44
SINGLE PROTEINHomo sapiens
Preferred name: CD44 antigen ChEMBL ↗
Linked proteins
Drugs acting on this target (11)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| urokinase-derived peptide a6 | Activator | experimental | Peptide | CD44 activator |
| cbt-1 | Antagonist | experimental | Small molecule | CD44 antagonist |
| bivatuzumab | Binding agent | experimental | mAb | CD44 binding agent |
| bivatuzumab mertansine | Binding agent | experimental | mAb | CD44 binding agent |
| cd44v6-specific car gene-engineered t cells | Immunity, passive | experimental | Cell therapy | CD44 immunity, passive |
| humnc2-car44 car t cells | Immunity, passive | experimental | Cell therapy | CD44 immunity, passive |
| mlm-car44.1 t-cell | Immunity, passive | experimental | Cell therapy | CD44 immunity, passive |
| amc303 | Inhibitor | experimental | Small molecule | CD44 inhibitor |
| bivatuzumab | Inhibitor | experimental | mAb | CD44 inhibitor |
| bivatuzumab mertansine | Inhibitor | experimental | mAb | CD44 inhibitor |
| ro5429083 | Inhibitor | experimental | mAb | CD44 inhibitor |